These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16370163)

  • 41. Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis.
    Koukoulaki M; Jayne DR
    Nephron Clin Pract; 2006; 102(3-4):c100-7. PubMed ID: 16286784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. B cell targeted therapies in autoimmune diseases.
    Isenberg DA
    J Rheumatol Suppl; 2006 May; 77():24-8. PubMed ID: 16652442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients.
    Harper L; Savage CO
    Rheumatology (Oxford); 2005 Apr; 44(4):495-501. PubMed ID: 15613403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A case report of steroid-resistant antineutrophil cytoplasmic antibody-related vasculitis successfully treated by mizoribine in a hemodialysis patient.
    Tokunaga M; Tamura M; Kabashima N; Serino R; Shibata T; Matsumoto M; Miyamoto T; Miyazaki M; Furuno Y; Fujimatsu S; Muta T; Takeuchi M; Abe H; Okazaki M; Otsuji Y
    Ther Apher Dial; 2009 Feb; 13(1):77-9. PubMed ID: 19379174
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of ANCA-associated vasculitis.
    Langford CA
    N Engl J Med; 2003 Jul; 349(1):3-4. PubMed ID: 12840085
    [No Abstract]   [Full Text] [Related]  

  • 46. [ANCA-positive vasculitis of the skin and kidneys associated with acne conglobata].
    Manz B; Rytter M; Mittag M; Seidel W; Nenoff P
    Hautarzt; 2002 Nov; 53(11):730-4. PubMed ID: 12402135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Goodpasture syndrome associated with p-ANCA microscopic vasculitis: a rare entity to recognize].
    Pralong G; Fournier C; Dayer E; Meier P
    Rev Med Suisse; 2009 Jun; 5(207):1330-4. PubMed ID: 19626934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic vasculitis: still a challenging disease.
    Buhaescu I; Covic A; Levy J
    Am J Kidney Dis; 2005 Aug; 46(2):173-85. PubMed ID: 16112036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Initial results of multicenter, randomized, controlled therapy studies of ANCA-associated vasculitis].
    De Groot K
    Z Rheumatol; 2002 Oct; 61(5):607-9. PubMed ID: 12399892
    [No Abstract]   [Full Text] [Related]  

  • 50. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis.
    Gao Y; Chen M; Ye H; Yu F; Guo XH; Zhao MH
    Rheumatology (Oxford); 2008 Oct; 47(10):1515-20. PubMed ID: 18676500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vasculitis of the gallbladder: case report and spectrum of disease.
    Juliano J; Wilson KD; Gertner E
    J Clin Rheumatol; 2009 Mar; 15(2):75-7. PubMed ID: 19265351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study.
    Yang L; Xie H; Liu Z; Chen Y; Wang J; Zhang H; Ge Y; Hu W
    BMC Nephrol; 2018 Jun; 19(1):138. PubMed ID: 29902982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Are there different forms of life in the antineutrophil cytoplasmic antibody universe?
    Hoffman GS; Langford CA
    Ann Intern Med; 2005 Nov; 143(9):683-5. PubMed ID: 16263891
    [No Abstract]   [Full Text] [Related]  

  • 54. Organ transplantation in the vasculitides.
    Schmitt WH; van der Woude FJ
    Curr Opin Rheumatol; 2003 Jan; 15(1):22-8. PubMed ID: 12496506
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function.
    McGregor JG; Negrete-Lopez R; Poulton CJ; Kidd JM; Katsanos SL; Goetz L; Hu Y; Nachman PH; Falk RJ; Hogan SL
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1(Suppl 1):i171-81. PubMed ID: 25805747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Severe gastrointestinal cytomegalovirus disease in two patients with renal vasculitis after immunosuppression.
    Lee KG; Teo SH; Lim C; Loh A; Chidambaram V; Choo J
    Clin Nephrol; 2016 Sep; 86(9):154-61. PubMed ID: 27443566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
    Hu W; Liu C; Xie H; Chen H; Liu Z; Li L
    Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ANCA-associated vasculitides: pathogenetic aspects and current evidence-based therapy.
    Holle JU; Gross WL
    J Autoimmun; 2009; 32(3-4):163-71. PubMed ID: 19345067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How to diagnose and treat secondary forms of vasculitis.
    Luqmani RA; Pathare S; Kwok-Fai TL
    Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):321-36. PubMed ID: 15857799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mizoribine induces remission of relapsed ANCA-associated renal vasculitis.
    Nishioka Y; Horita Y; Tadokoro M; Taura K; Suyama N; Miyazaki M; Harada T; Kohno S
    Nephrol Dial Transplant; 2006 Apr; 21(4):1087-8. PubMed ID: 16326748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.